Form 4 for PCVX Vaxcyte, Inc.
Accepted 2021-08-18 00:00:00 ET · period of report 2021-08-16 · accession 0001209191-21-052311 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-18 | 2021-08-16 | PCVX | Wright-Mitchell Jane | GC | S - Sale+OE | $26.00 | -2,500 | 3,125 | -44% | -$65.0K |
| D | 2021-08-18 | 2021-08-16 | PCVX | Wright-Mitchell Jane | GC | M - OptEx | $2.03 | +2,500 | 5,625 | +80% | +$5,075 |
| D | 2021-08-18 | 2021-08-16 | PCVX | Wright-Mitchell Jane | GC | M - OptEx | $0.00 | -2,500 | 187.5K | -1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-16 | S | D | 2,500 | $26.00 | 3,125 | D | — | — | |
| 2 | Common | Common Stock | 2021-08-16 | M | A | 2,500 | $2.03 | 5,625 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2021-08-16 | M | D | 2,500 | $0.00 | 187,468 | D | $2.03 · — to 2029-03-20 | 2,500 Common Stock | (F2) 1/4 of the shares subject to the option vested on January 7, 2020, and 1/48 of the shares vest monthly thereafter. |